학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 85건 | 목록 1~20
Academic Journal
Regnault R; ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU Lille, University Lille, F-59000 Lille, France.; Klupsch F; U1286-INFINITE-Institute for Translational Research in Inflammation, ICPAL, Inserm, University Lille, F-59000 Lille, France.; El-Bouazzati H; UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Inserm, CNRS, CHU Lille, University Lille, F-59000 Lille, France.; Magnez R; UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Inserm, CNRS, CHU Lille, University Lille, F-59000 Lille, France.; Le Biannic R; U1286-INFINITE-Institute for Translational Research in Inflammation, ICPAL, Inserm, University Lille, F-59000 Lille, France.; Leleu-Chavain N; U1286-INFINITE-Institute for Translational Research in Inflammation, ICPAL, Inserm, University Lille, F-59000 Lille, France.; Ahouari H; LASIRE Laboratoire Avancé de Spectroscopie pour les Intéractions la Réactivité et l'Environnement, F-59655 Villeneuve d'Ascq, France.; FR 2638-IMEC-Institut Michel-Eugène Chevreul, University Lille, F-59655 Lille, France.; Vezin H; LASIRE Laboratoire Avancé de Spectroscopie pour les Intéractions la Réactivité et l'Environnement, F-59655 Villeneuve d'Ascq, France.; Millet R; U1286-INFINITE-Institute for Translational Research in Inflammation, ICPAL, Inserm, University Lille, F-59000 Lille, France.; Goossens JF; ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU Lille, University Lille, F-59000 Lille, France.; Thuru X; UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Inserm, CNRS, CHU Lille, University Lille, F-59000 Lille, France.; Bailly C; UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Inserm, CNRS, CHU Lille, University Lille, F-59000 Lille, France.; Oncowitan, Scientific Consulting Office, Wasquehal, F-59290 Lille, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE
Academic Journal
Gaggero S; Inserm UMR1277, CNRS UMR9020-CANTHER, Université de Lille, Lille University Hospital, Lille, France.; Martinez-Fabregas J; Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK.; Cozzani A; Inserm UMR1277, CNRS UMR9020-CANTHER, Université de Lille, Lille University Hospital, Lille, France.; Fyfe PK; Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK.; Leprohon M; Inserm UMR1277, CNRS UMR9020-CANTHER, Université de Lille, Lille University Hospital, Lille, France.; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France.; Yang J; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, UK.; Thomasen FE; Structural Biology and NMR Laboratory, Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, DK-2200 Copenhagen, Denmark.; Winkelmann H; Department of Biology/Chemistry and Center for Cellular Nanoanalytics (CellNanOs), Osnabrück University, Barbarastr. 11, 49076 Osnabrück, Germany.; Magnez R; Inserm UMR1277, CNRS UMR9020-CANTHER, Université de Lille, Lille University Hospital, Lille, France.; Conti AG; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, UK.; Wilmes S; Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK.; Pohler E; Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK.; van Gijsel Bonnello M; Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK.; Thuru X; Inserm UMR1277, CNRS UMR9020-CANTHER, Université de Lille, Lille University Hospital, Lille, France.; Quesnel B; Inserm UMR1277, CNRS UMR9020-CANTHER, Université de Lille, Lille University Hospital, Lille, France.; Soncin F; CNRS/IIS/Centre Oscar Lambret/Lille University SMMiL-E Project, CNRS Délégation Hauts-de-France, Lille, France.; CNRS IRL 2820; Laboratory for Integrated Micro Mechatronic Systems, Institute of Industrial Science, University of Tokyo, Tokyo, Japan.; Piehler J; Department of Biology/Chemistry and Center for Cellular Nanoanalytics (CellNanOs), Osnabrück University, Barbarastr. 11, 49076 Osnabrück, Germany.; Lindorff-Larsen K; Structural Biology and NMR Laboratory, Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, DK-2200 Copenhagen, Denmark.; Roychoudhuri R; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, UK.; Moraga I; Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK.; Mitra S; Inserm UMR1277, CNRS UMR9020-CANTHER, Université de Lille, Lille University Hospital, Lille, France.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE
Academic Journal
Leleu-Chavain N; Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Lille Inflammation Research International Center, ICPAL, 3 Rue du Professeur Laguesse, 59000 Lille, France.; Regnault R; Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, 59000 Lille, France.; Ahouari H; LASIRE Laboratoire Avancé de Spectroscopie pour les Intéractions la Réactivité et l'Environnement, 59655 Villeneuve d'Ascq, France.; Univ. Lille, FR 2638-IMEC-Institut Michel-Eugène Chevreul, 59655 Lille, France.; Le Biannic R; Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Lille Inflammation Research International Center, ICPAL, 3 Rue du Professeur Laguesse, 59000 Lille, France.; Kouach M; Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, 59000 Lille, France.; Klupsch F; Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Lille Inflammation Research International Center, ICPAL, 3 Rue du Professeur Laguesse, 59000 Lille, France.; Magnez R; Univ. Lille, CHU Lille, CNRS, Inserm, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000 Lille, France.; Vezin H; LASIRE Laboratoire Avancé de Spectroscopie pour les Intéractions la Réactivité et l'Environnement, 59655 Villeneuve d'Ascq, France.; Thuru X; Univ. Lille, CHU Lille, CNRS, Inserm, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000 Lille, France.; Bailly C; Oncowitan, Scientific Consulting Office, 59290 Lille, France.; Goossens JF; Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, 59000 Lille, France.; Millet R; Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Lille Inflammation Research International Center, ICPAL, 3 Rue du Professeur Laguesse, 59000 Lille, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE
Academic Journal
Thuru X; Inserm, CHU Lille, CNRS, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, University Lille, Lille, France.; Magnez R; Inserm, CHU Lille, CNRS, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, University Lille, Lille, France.; Vergoten G; Inserm, INFINITE - U1286, Institut de Chimie Pharmaceutique Albert Lespagnol (ICPAL), Faculté de Pharmacie, University of Lille, Lille, France.; Bailly C; Inserm, CHU Lille, CNRS, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, University Lille, Lille, France.; Oncowitan, Scientific Consulting Office, Lille (Wasquehal), France.
Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101692630 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-6870 (Electronic) Linking ISSN: 22966870 NLM ISO Abbreviation: Biomed Hub Subsets: PubMed not MEDLINE
Academic Journal
Coku I; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Mutez E; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; University of Lille, Inserm, CHU Lille, Expert Center for Parkinson's Disease, Lille, France.; Eddarkaoui S; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Carrier S; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Marchand A; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Deldycke C; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Goveas L; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Baille G; University of Lille, Inserm, CHU Lille, Expert Center for Parkinson's Disease, Lille, France.; Tir M; Department of Neurology and Expert Center for Parkinson's Disease, Amiens University Hospital, CHU Amiens-Picardie, Amiens, France.; Magnez R; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.; Thuru X; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.; Vermeersch G; Department of Neurology, AZ Sint-Lucas, Bruges, Belgium.; Vandenberghe W; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.; Laboratory for Parkinson Research, Department of Neurosciences, KU Leuven, Leuven, Belgium.; Buée L; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Defebvre L; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; University of Lille, Inserm, CHU Lille, Expert Center for Parkinson's Disease, Lille, France.; Sablonnière B; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; University of Lille, Inserm, CHU Lille, Department of Toxicology and Genopathies, UF Neurobiology, Lille, France.; Chartier-Harlin MC; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Taymans JM; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; Huin V; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; University of Lille, Inserm, CHU Lille, Department of Toxicology and Genopathies, UF Neurobiology, Lille, France.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE
Academic Journal
Lucescu L; Faculty of Chemistry, Al. I. Cuza' University of Iasi, Iasi, Romania.; Ghinet A; Faculty of Chemistry, Al. I. Cuza' University of Iasi, Iasi, Romania.; Inserm U995, LIRIC, Faculté de médecine-Pôle recherche, Université de Lille, CHRU de Lille, Lille, France.; Laboratoire de Chimie Durable et Santé, Hautes Etudes d'Ingénieur (HEI), Yncréa Hauts-de-France, UC Lille, Lille, France.; Shova S; Petru Poni' Institute of Macromolecular Chemistry, Iasi, Romania.; Magnez R; Univ. Lille, UMR-S 1172 - JPARC - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, Lille, France.; Thuru X; Univ. Lille, UMR-S 1172 - JPARC - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, Lille, France.; Farce A; Inserm U995, LIRIC, Faculté de médecine-Pôle recherche, Université de Lille, CHRU de Lille, Lille, France.; Faculté des Sciences Pharmaceutiques et Biologiques de Lille, Lille, France.; Rigo B; Inserm U995, LIRIC, Faculté de médecine-Pôle recherche, Université de Lille, CHRU de Lille, Lille, France.; Laboratoire de Chimie Durable et Santé, Hautes Etudes d'Ingénieur (HEI), Yncréa Hauts-de-France, UC Lille, Lille, France.; Belei D; Faculty of Chemistry, Al. I. Cuza' University of Iasi, Iasi, Romania.; Dubois J; Centre de Recherche de Gif, Institut de Chimie des Substances Naturelles, UPR2301 CNRS, Gif-sur-Yvette, France.; Bîcu E; Faculty of Chemistry, Al. I. Cuza' University of Iasi, Iasi, Romania.
Publisher: Wiley-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 0330167 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4184 (Electronic) Linking ISSN: 03656233 NLM ISO Abbreviation: Arch Pharm (Weinheim) Subsets: MEDLINE
Academic Journal
Le Biannic R; Univ. Lille, Inserm, U1286 - INFINITE - Lille Inflammation Research International Center, ICPAL, 3 rue du Professeur Laguesse, 59000, Lille, France. Electronic address: raphael.le-biannic@univ-lille.fr.; Magnez R; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020 - UMR1277, Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, 1 place de Verdun, 59000, Lille, France.; Klupsch F; Univ. Lille, Inserm, U1286 - INFINITE - Lille Inflammation Research International Center, ICPAL, 3 rue du Professeur Laguesse, 59000, Lille, France.; Leleu-Chavain N; Univ. Lille, Inserm, U1286 - INFINITE - Lille Inflammation Research International Center, ICPAL, 3 rue du Professeur Laguesse, 59000, Lille, France.; Thiroux B; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020 - UMR1277, Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, 1 place de Verdun, 59000, Lille, France.; Tardy M; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020 - UMR1277, Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, 1 place de Verdun, 59000, Lille, France.; El Bouazzati H; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020 - UMR1277, Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, 1 place de Verdun, 59000, Lille, France.; Dezitter X; Univ. Lille, Inserm, U1286 - INFINITE - Lille Inflammation Research International Center, ICPAL, 3 rue du Professeur Laguesse, 59000, Lille, France.; Renault N; Univ. Lille, Inserm, U1286 - INFINITE - Lille Inflammation Research International Center, ICPAL, 3 rue du Professeur Laguesse, 59000, Lille, France.; Vergoten G; Univ. Lille, Inserm, U1286 - INFINITE - Lille Inflammation Research International Center, ICPAL, 3 rue du Professeur Laguesse, 59000, Lille, France.; Bailly C; Oncowitan, Lille, France.; Quesnel B; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020 - UMR1277, Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, 1 place de Verdun, 59000, Lille, France.; Thuru X; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020 - UMR1277, Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, 1 place de Verdun, 59000, Lille, France. Electronic address: xavier.thuru@univ-lille.fr.; Millet R; Univ. Lille, Inserm, U1286 - INFINITE - Lille Inflammation Research International Center, ICPAL, 3 rue du Professeur Laguesse, 59000, Lille, France. Electronic address: regis.millet@univ-lille.fr.
Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE
Academic Journal
Journal of Elementology. Sep2008, Vol. 13 Issue 3, p391-399. 9p. 3 Charts.
Academic Journal
Trouvilliez S; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Cicero J; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; University Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), F-62300, Lens, France.; Lévêque R; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Aubert L; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Corbet C; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Van Outryve A; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Streule K; Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, 76344, Eggenstein-Leopoldshafen, Germany.; Angrand PO; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Völkel P; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Magnez R; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Brysbaert G; University Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France.; Mysiorek C; University Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), F-62300, Lens, France.; Gosselet F; University Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), F-62300, Lens, France.; Bourette R; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Adriaenssens E; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Thuru X; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Lagadec C; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; de Ruyck J; University Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France.; Orian-Rousseau V; Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, 76344, Eggenstein-Leopoldshafen, Germany.; Le Bourhis X; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Toillon RA; University Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France. robert-alain.toillon@univ-lille.fr.; Université de Lille, Faculté des Sciences et Technologies, UMR CNRS 9020- INSERM U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Bâtiment SN3, 3ème étage, Cité scientifique, 59655, Villeneuve d'Ascq, France. robert-alain.toillon@univ-lille.fr.
Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
Academic Journal
Stoup N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Liberelle M; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, F-59000 Lille, France.; Schulz C; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Cavdarli S; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Vasseur R; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Magnez R; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Lahdaoui F; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Skrypek N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Peretti F; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Frénois F; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Thuru X; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Melnyk P; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, F-59000 Lille, France.; Renault N; Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France.; Jonckheere N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Lebègue N; Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neurosciences & Cognition, F-59000 Lille, France.; Van Seuningen I; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Magnez R; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000 Lille, France.; Bailly C; Oncowitan, Scientific Consulting Office, 59045 Lille, France.; Thuru X; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000 Lille, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Academic Journal
Thuru X; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Magnez R; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; El-Bouazzati H; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Vergoten G; Institut de Chimie Pharmaceutique Albert Lespagnol (ICPAL), Faculté de Pharmacie, University of Lille, Inserm, INFINITE-U1286, 3 Rue du Professeur Laguesse, BP-83, F-59006 Lille, France.; Quesnel B; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Bailly C; Oncowitan, Scientific Consulting Office, F-59290 Lille, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Sturbaut M; Univ Lille, INSERM, CHU Lille, UMR-S 1172, Lille Neuroscience and Cognition Research Center, F-59000, Lille, France.; Bailly F; Univ Lille, INSERM, CHU Lille, UMR-S 1172, Lille Neuroscience and Cognition Research Center, F-59000, Lille, France.; Coevoet M; Univ Lille, INSERM, CHU Lille, UMR-S 1172, Lille Neuroscience and Cognition Research Center, F-59000, Lille, France.; Sileo P; Univ Lille, INSERM, CHU Lille, UMR-S 1172, Lille Neuroscience and Cognition Research Center, F-59000, Lille, France.; Pugniere M; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194 - ICM, UM 208 rue des Apothicaires, F-34298, Montpellier Cedex 5, France.; Liberelle M; Univ Lille, INSERM, CHU Lille, UMR-S 1172, Lille Neuroscience and Cognition Research Center, F-59000, Lille, France.; Magnez R; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Platform of Integrative Chemical Biology, F-59000, Lille, France.; Thuru X; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Platform of Integrative Chemical Biology, F-59000, Lille, France.; Chartier-Harlin MC; Univ Lille, INSERM, CHU Lille, UMR-S 1172, Lille Neuroscience and Cognition Research Center, F-59000, Lille, France.; Melnyk P; Univ Lille, INSERM, CHU Lille, UMR-S 1172, Lille Neuroscience and Cognition Research Center, F-59000, Lille, France.; Gelin M; Centre de Biologie Structurale (CBS), CNRS, INSERM, Univ Montpellier, Montpellier, France.; Allemand F; Centre de Biologie Structurale (CBS), CNRS, INSERM, Univ Montpellier, Montpellier, France.; Guichou JF; Centre de Biologie Structurale (CBS), CNRS, INSERM, Univ Montpellier, Montpellier, France. Electronic address: guichou@cbs.cnrs.fr.; Cotelle P; Univ Lille, INSERM, CHU Lille, UMR-S 1172, Lille Neuroscience and Cognition Research Center, F-59000, Lille, France; ENSCL-Centrale Lille, CS 90108, F-59652, Villeneuve d'Ascq Cedex, France. Electronic address: philippe.cotelle@univ-lille.fr.
Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE
Academic Journal
Rico T; Univ. Lille, INSERM, CHU-Lille, Lille Neuroscience and Cognition, UMR-S1172, Alzheimer and Tauopathies, Lille, France.; Gilles M; Univ. Lille, INSERM, CHU-Lille, Lille Neuroscience and Cognition, UMR-S1172, Alzheimer and Tauopathies, Lille, France.; Chauderlier A; Univ. Lille, INSERM, CHU-Lille, Lille Neuroscience and Cognition, UMR-S1172, Alzheimer and Tauopathies, Lille, France.; Comptdaer T; Univ. Lille, INSERM, CHU-Lille, Lille Neuroscience and Cognition, UMR-S1172, Alzheimer and Tauopathies, Lille, France.; Magnez R; Univ. Lille, CNRS, INSERM, CHU Lille, UMR 9020, UMR 1277, Canther, Platform of Integrative Chemical Biology, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Chwastyniak M; Univ. Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de Risque et Déterminants Moléculaires des Maladies Liées Au Vieillissement, Lille, France.; Drobecq H; Univ. Lille, CNRS UMR 9017, INSERM U1019, CHRU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.; Pinet F; Univ. Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de Risque et Déterminants Moléculaires des Maladies Liées Au Vieillissement, Lille, France.; Thuru X; Univ. Lille, CNRS, INSERM, CHU Lille, UMR 9020, UMR 1277, Canther, Platform of Integrative Chemical Biology, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Buée L; Univ. Lille, INSERM, CHU-Lille, Lille Neuroscience and Cognition, UMR-S1172, Alzheimer and Tauopathies, Lille, France.; Galas MC; Univ. Lille, INSERM, CHU-Lille, Lille Neuroscience and Cognition, UMR-S1172, Alzheimer and Tauopathies, Lille, France.; Lefebvre B; Univ. Lille, INSERM, CHU-Lille, Lille Neuroscience and Cognition, UMR-S1172, Alzheimer and Tauopathies, Lille, France.
Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Liberelle M; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Magnez R; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Thuru X; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Bencheikh Y; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Ravez S; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Quenon C; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Drucbert AS; CHU Lille, Banque de tissus, F-59000, Lille, France.; Foulon C; Univ. Lille, EA 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000, Lille, France.; Melnyk P; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Van Seuningen I; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Lebègue N; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France. nicolas.lebegue@univ-lille.fr.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Liberelle M; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Magnez R; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Thuru X; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Bencheikh Y; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Ravez S; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Quenon C; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Drucbert AS; CHU Lille, Banque de tissus, F-59000, Lille, France.; Foulon C; Univ. Lille, EA 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000, Lille, France.; Melnyk P; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Van Seuningen I; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France.; Lebègue N; Univ. Lille, Inserm, CHU Lille, UMR-S1172 - JPArc - Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000, Lille, France. nicolas.lebegue@univ-lille.fr.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Ekologia i Technika. 22(3):106-110
검색 결과 제한하기
제한된 항목
[검색어] Magnez, R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어